Related Experiment Video
Updated: May 30, 2026

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration
Kevin Zarrabi1, Antoine Dufour, Jian Li
1Department of Medicine/Cancer Prevention, Stony Brook University, Stony Brook, New York 11794, USA.
Abstract:
Matrix metalloproteinases (MMPs) have been shown to be key players in both extracellular matrix remodeling and cell migration during cancer metastasis. MMP-14, a membrane-anchored MMP, in particular, is closely associated with these processes. The hemopexin (PEX) domain of MMP-14 has been proposed as the modulating region involved in the molecular cross-talk that initiates cell migration through homodimerization of MMP-14 as well as heterodimerization with the cell surface adhesion molecule CD44. In this study, minimal regions required for function within the PEX domain were investigated through a series of substitution mutations. Blades I and IV were found to be involved in cell migration. We found that blade IV is necessary for MMP-14 homodimerization and that blade I is required for CD44 MMP-14 heterodimerization. Cross-talk between MMP-14 and CD44 results in phosphorylation of EGF receptor and downstream activation of the MAPK and PI3K signaling pathways involved in cell migration. Based on these mutagenesis analyses, peptides mimicking the essential outermost strand motifs within the PEX domain of MMP-14 were designed. These synthetic peptides inhibit MMP-14-enhanced cell migration in a dose-dependent manner but have no effect on the function of other MMPs. Furthermore, these peptides interfere with cancer metastasis without affecting primary tumor growth. Thus, targeting the MMP-14 hemopexin domain represents a novel approach to inhibit MMP-14-mediated cancer dissemination.
Insights
Matrix metalloproteinase-14 (MMP-14) drives cancer metastasis via its hemopexin domain. Novel peptides targeting this domain inhibit metastasis without affecting tumor growth, offering a new therapeutic strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Matrix metalloproteinases (MMPs) facilitate extracellular matrix remodeling and cell migration, crucial for cancer metastasis.
- MMP-14, a membrane-anchored MMP, is particularly implicated in these metastatic processes.
- The hemopexin (PEX) domain of MMP-14 is hypothesized to mediate cell migration through MMP-14 homodimerization and heterodimerization with CD44.
Purpose of the Study:
- To identify the minimal functional regions within the MMP-14 PEX domain responsible for cell migration.
- To investigate the role of specific PEX domain regions in MMP-14 homodimerization and CD44 heterodimerization.
- To develop and evaluate peptide inhibitors targeting the MMP-14 PEX domain for anti-metastatic therapy.
Main Methods:
- Site-directed mutagenesis to probe functional regions within the MMP-14 PEX domain.
- Analysis of MMP-14 homodimerization and CD44 heterodimerization.
- Design and synthesis of peptides mimicking critical PEX domain motifs.
- In vitro assays to assess peptide inhibition of MMP-14-enhanced cell migration and metastasis models.
Main Results:
- Mutagenesis identified Blades I and IV of the PEX domain as critical for cell migration.
- Blade IV is essential for MMP-14 homodimerization, while Blade I is required for CD44-MMP-14 heterodimerization.
- MMP-14/CD44 cross-talk activates EGF receptor, MAPK, and PI3K signaling pathways.
- Synthetic peptides targeting the PEX domain effectively inhibited MMP-14-mediated cell migration and metastasis in a dose-dependent manner.
- These peptides demonstrated efficacy against metastasis without impacting primary tumor growth.
Conclusions:
- The MMP-14 PEX domain contains essential regions (Blades I and IV) critical for mediating cancer cell migration and metastasis.
- Targeting the MMP-14 PEX domain with specific peptide inhibitors represents a promising and selective strategy to combat cancer dissemination.
- This approach offers a novel therapeutic avenue for inhibiting metastasis without compromising primary tumor development.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Role of Matrix Metalloproteases in Degradation of ECM
A...
Inhibition of Cdk Activity
Inhibition of CDK Activity